Scientific Research Department, Cangzhou Central Hospital, Cangzhou, Hebei Province, China.
Respiratory Ward One, Cangzhou Central Hospital, Cangzhou, Hebei Province, China.
Aging (Albany NY). 2020 Nov 20;12(24):25767-25777. doi: 10.18632/aging.104187.
Non-small cell lung cancer (NSCLC) is one of the most common malignancies worldwide. The use of a combination of chemotherapy drugs and zinc oxide nanoparticles (ZnO-NPs), which have proven to induce tumor-selective cell death, reduce the drug resistance and reduce the side effects . In the present study, we developed ZnO-NPs loaded with both cisplatin (Cp) and gemcitabine (Gem) (ZnO-NPs(Cp/Gem)), then the morphologies and the size distribution of ZnO-NPs(Cp/Gem) particles were observed by transmission electron microscopy (TEM) and dynamic light scattering (DLS). Also, MTT, western blot and Annexin V-PI were used to assess the anti-tumor role of ZnO-NPs(Cp/Gem) in A549 cells. The viability for A549 cells showed a significant decrease in the ZnO NPs(Cp/Gem) group, respectively relative to Cp, Gem, the combination of Cp and Gem (Cp+Gem), and ZnO-NPs loaded with Cp (ZnO-NPs(Cp)) or Gem (ZnO-NPs(Gem)). Furthermore, ZnO-NPs(Cp/Gem) remarkably enhanced the apoptosis-promoting effect of Cp and Gem in A549 cells. The xenograft model showed that Zno-NPS (Cp/Gem) significantly enhanced the inhibition of Cp and Gem on tumor formation. The above results suggested that therapy of NSCLC with ZnO-NPs(Cp/Gem) could enhance the cytotoxic action of chemotherapeutic agents synergistically, indicating a promising potential for ZnO-NPs in antitumor applications.
非小细胞肺癌(NSCLC)是世界上最常见的恶性肿瘤之一。联合使用化疗药物和氧化锌纳米粒子(ZnO-NPs)已被证明能诱导肿瘤选择性细胞死亡,降低耐药性并减少副作用。在本研究中,我们开发了负载顺铂(Cp)和吉西他滨(Gem)的 ZnO-NPs(ZnO-NPs(Cp/Gem)),然后通过透射电子显微镜(TEM)和动态光散射(DLS)观察 ZnO-NPs(Cp/Gem)颗粒的形态和粒径分布。此外,还使用 MTT、western blot 和 Annexin V-PI 来评估 ZnO-NPs(Cp/Gem)在 A549 细胞中的抗肿瘤作用。与 Cp、Gem、Cp 和 Gem 的联合(Cp+Gem)以及负载 Cp 的 ZnO-NPs(ZnO-NPs(Cp))或 Gem 的 ZnO-NPs(ZnO-NPs(Gem))相比,A549 细胞的活力显著下降。此外,ZnO-NPs(Cp/Gem)显著增强了 Cp 和 Gem 在 A549 细胞中的促凋亡作用。异种移植模型表明,Zno-NPS(Cp/Gem)显著增强了 Cp 和 Gem 对肿瘤形成的抑制作用。上述结果表明,用 ZnO-NPs(Cp/Gem)治疗 NSCLC 可以协同增强化疗药物的细胞毒性作用,表明 ZnO-NPs 在抗肿瘤应用中具有很大的应用潜力。